Coordinación
Carrer Baldiri Reixac, 4-8
08028 Barcelona
93 403 11 02 / reem@reem.es

1. Neuroimmunology line
2. Neurodegeneration / Regeneration line
3. Genomics line
4. Virus line
5. Biomarker line
6. Clinical marker for MS treatment line
7. New therapies line

Coordinator:
Groups:
Instituto de Química Médica de Madrid
IDIBAPS
Hospital Nacional de Parapléjicos de Toledo
Hospital Carlos Haya
Institut de Recerca Vall d'Hebron
Objetives: The identification of new therapeutical targets to devlop new possible therapies to confront MS.

